Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-27

FDA Approved: ONZETRA XSAIL — Original Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved the original application for ONZETRA XSAIL (sumatriptan succinate) from Currax Pharmaceuticals LLC. It is intended for the acute treatment of m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONZETRA XSAIL (Sumatriptan succinate)

Snippet

ORIG AP for ONZETRA XSAIL (SUMATRIPTAN SUCCINATE)